Veglia F, Tyurin V, Blasi M, De Leo A, Kossenkov A, Donthireddy L, et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 2019;569:73-78 pubmed publisher

Suschak J, BAGLEY K, Shoemaker C, Six C, Kwilas S, Dupuy L, et al. The Genetic Adjuvants Interleukin-12 and Granulocyte-Macrophage Colony Stimulating Factor Enhance the Immunogenicity of an Ebola Virus Deoxyribonucleic Acid Vaccine in Mice. J Infect Dis. 2018;218:S519-S527 pubmed publisher

Obermajer N, Urban J, Wieckowski E, Muthuswamy R, Ravindranathan R, Bartlett D, et al. Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents. Nat Protoc. 2018;13:335-357 pubmed publisher

Bourgeois Daigneault M, Roy D, Aitken A, El Sayes N, Martin N, Varette O, et al. Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy. Sci Transl Med. 2018;10: pubmed publisher

Wen J, Tang W, Sheets N, Ellison J, Sette A, Kim K, et al. Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells. Nat Microbiol. 2017;2:17036 pubmed publisher

Gil L, Cobas K, Lazo L, Marcos E, Hernandez L, Suzarte E, et al. A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys. J Immunol. 2016;197:3597-3606 pubmed

Goff P, Hayashi T, Martínez Gil L, Corr M, Crain B, Yao S, et al. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses. J Virol. 2015;89:3221-35 pubmed publisher

Lindestam Arlehamn C, Paul S, Mele F, Huang C, Greenbaum J, Vita R, et al. Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopes. Proc Natl Acad Sci U S A. 2015;112:E147-55 pubmed publisher

Helm F, Kammertoens T, Lehmann F, Wilke A, Bruns H, Mautner J, et al. Targeting c-MYC with T-cells. PLoS ONE. 2013;8:e77375 pubmed publisher

Pihlgren M, Silva A, Madani R, Giriens V, Waeckerle Men Y, Fettelschoss A, et al. TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell-independent isotype switch in mice. Blood. 2013;121:85-94 pubmed publisher

Wiessner C, Wiederhold K, Tissot A, Frey P, Danner S, Jacobson L, et al. The second-generation active A? immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects. J Neurosci. 2011;31:9323-31 pubmed publisher

Johannsen A, Genolet R, Legler D, Luther S, Luescher I. Definition of key variables for the induction of optimal NY-ESO-1-specific T cells in HLA transgene mice. J Immunol. 2010;185:3445-55 pubmed publisher

Gregor P, Wolchok J, Ferrone C, Buchinshky H, Guevara Patino J, Perales M, et al. CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems. Vaccine. 2004;22:1700-8 pubmed